Literature DB >> 10917557

Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden.

A M Ekström1, L E Hansson, L B Signorello, A Lindgren, R Bergström, O Nyrén.   

Abstract

While the overall incidence of gastric cancer has fallen, presumably to a large extent in parallel with Helicobacter pylori infection, the occurrence of the diffuse histologic type is thought to have remained more stable, questioning the aetiologic role of H. pylori. We have analysed the incidence of the intestinal and diffuse types separately, while considering subsite (cardia/non-cardia). With an extensive prospective effort we identified all incident cases of gastric adenocarcinoma (n = 1337) in a well-defined Swedish population (1.3 million) 1989-1994. Tumours were uniformly classified histologically and topographically. Subgroup-specific incidence rates were computed and modelled using multivariate logistic regression. Site-specific trends were clearly discrepant. The overall incidence of adenocarcinoma distal to the gastric cardia declined by 9% (95% confidence interval 6-12%) per year, while cardia cancer remained stable. Thus, the feared rise in cardia cancer could not be confirmed despite clear site-specific trend discrepancies. The intestinal type predominated, especially in high-risk areas, while diffuse tumours prevailed among young patients and women. Both main histologic types of gastric adenocarcinoma declined markedly, at similar rapidity, and with no significant trend differences between the intestinal and diffuse types, even after multivariate adjustments. Our results are consistent with an aetiologic role of environmental factors including H. pylori also for diffuse-type gastric cancers.

Entities:  

Mesh:

Year:  2000        PMID: 10917557      PMCID: PMC2374560          DOI: 10.1054/bjoc.2000.1205

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists.

Authors:  J Parsonnet; M J Blaser; G I Perez-Perez; N Hargrett-Bean; R V Tauxe
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

Review 2.  The decline in gastric cancer: epidemiology of an unplanned triumph.

Authors:  C P Howson; T Hiyama; E L Wynder
Journal:  Epidemiol Rev       Date:  1986       Impact factor: 6.222

3.  Decreased incidences of intestinal and diffuse types of gastric carcinoma in Finland during a 20-year period.

Authors:  P Sipponen; O Järvi; M Kekki; M Siurala
Journal:  Scand J Gastroenterol       Date:  1987-09       Impact factor: 2.423

4.  Family behaviour of gastric carcinoma.

Authors:  J Lehtola
Journal:  Ann Clin Res       Date:  1981-06

5.  Changes in the location and type of gastric adenocarcinoma.

Authors:  D A Antonioli; H Goldman
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

6.  Gastric cancer in a high-risk area in Italy. Histopathologic patterns according to Lauren's classification.

Authors:  A Amorosi; S Bianchi; E Buiatti; F Cipriani; D Palli; G Zampi
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  [New aspects of early gastric carcinoma].

Authors:  C Mennicken; M H Bohrer; M Jung; B C Manegold
Journal:  Dtsch Med Wochenschr       Date:  1986-02-14       Impact factor: 0.628

8.  Definition of carcinoma of the gastric cardia.

Authors:  A Misumi; A Murakami; K Harada; K Baba; M Akagi
Journal:  Langenbecks Arch Chir       Date:  1989

9.  Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982.

Authors:  P C Yang; S Davis
Journal:  Int J Epidemiol       Date:  1988-06       Impact factor: 7.196

10.  Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951.

Authors:  G Lundegårdh; A Lindgren; A Rohul; O Nyrén; L E Hansson; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  9 in total

1.  Advanced gastric cancer in jordan from 2004 to 2008: a study of epidemiology and outcomes.

Authors:  Salah Y Abbasi; Hani El Taani; Adnan Saad; Ahmed Badheeb; Ala' Addasi
Journal:  Gastrointest Cancer Res       Date:  2011-07

2.  IgA deficiency and risk of cancer: a population-based matched cohort study.

Authors:  Jonas F Ludvigsson; Martin Neovius; Weimin Ye; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2015-01-15       Impact factor: 8.317

Review 3.  Chemotherapy as a component of multimodal therapy for gastric carcinoma.

Authors:  Yasuhiro Kodera; Michitaka Fujiwara; Masahiko Koike; Akimasa Nakao
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

4.  The correlation between gastric cancer screening method and the clinicopathologic features of gastric cancer.

Authors:  Ji-Youn Han; Hyehyun Son; Won Chul Lee; Byung Gil Choi
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

5.  Gastric malignancies in Northern Jordan with special emphasis on descriptive epidemiology.

Authors:  Kamal-E Bani-Hani; Rami-J Yaghan; Hussein-A Heis; Nawaf-J Shatnawi; Ismail-I Matalka; Amjad-M Bani-Hani; Kamal-A Gharaibeh
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

6.  D2 lymphadenectomy in the management of gastric cancer.

Authors:  J A McCullough; D Evoy; K J Sweeney; C Meyers; N Ravi; N Keeling; P J Byrne; J V Reynolds
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

7.  Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland.

Authors:  Elisabete Weiderpass; Eero Pukkala
Journal:  BMC Gastroenterol       Date:  2006-12-04       Impact factor: 3.067

8.  Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004: a study in one referral center in Iran.

Authors:  Afshin Abdi-Rad; Siavash Ghaderi-sohi; Hosein Nadimi-Barfroosh; Sara Emami
Journal:  Diagn Pathol       Date:  2006-05-11       Impact factor: 2.644

9.  Familial risk for gastric carcinoma: an updated study from Sweden.

Authors:  K Hemminki; J Sundquist; J Ji
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.